MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody® sonelokimab in hidradenitis suppurativa
Globe Newswire25-06-2023, 20:00
The UK, the Netherlands, Egypt and Saudi Arabia among likely winners in the changing world order 28-05-2025, 15:00